This invention pertains to polynucleotides, such as small interfering RNA (siRNA), useful for reducing the expression of respiratory syncytial virus (RSV) genes within a subject and methods for treating a patient suffering from, or at risk of developing, an RSV infection by administering such polynucleotides to the subject.